TMS 10 mg | 99.42%
TargetMol
TMS is a very selective and potent competitive inhibitor of P450 1B1 (CYP1A1).
More Information Supplier Page
TMS is a very selective and potent competitive inhibitor of P450 1B1 (CYP1A1).
More Information Supplier Page
TMS is a very selective and potent competitive inhibitor of P450 1B1 (CYP1A1).
More Information Supplier Page
JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).
More Information Supplier Page
JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).
More Information Supplier Page
JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).
More Information Supplier Page
JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).
More Information Supplier Page
(S)-ATPO is Competitive antagonist at GluR1-4 (AMPA-preferring) receptors.
More Information Supplier Page
(S)-ATPO is Competitive antagonist at GluR1-4 (AMPA-preferring) receptors.
More Information Supplier Page
(S)-ATPO is Competitive antagonist at GluR1-4 (AMPA-preferring) receptors.
More Information Supplier Page
(S)-ATPO is Competitive antagonist at GluR1-4 (AMPA-preferring) receptors.
More Information Supplier Page